TX PA Teriparatide Criteria Guide V10
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Clinical Criteria Information Included in this Document Forteo (Teriparatide) Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical criteria rules Logic diagram: a visual depiction of the clinical criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes) References: clinical publications and sources relevant to this clinical criteria Note: Click the hyperlink to navigate directly to that section. Revision Notes Annual review by staff Added GCN for teriparatide (47023) to PA drug table Added diagnoses for osteoporosis (Table 3) Update references October 18, 2022 Copyright 2022 Health Information Designs, LLC 1
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Forteo (Teriparatide) Drugs Requiring Prior Authorization The listed GCNS may not be an indication of TX Medicaid Formulary coverage. To learn the current formulary coverage, visit TxVendorDrug.com/formulary/formulary-search. Drugs Requiring Prior Authorization Label Name GCN FORTEO 600MCG/2.4ML PEN INJ 14404 TERIPARATIDE 620MCG/2.48ML 47023 October 18, 2022 Copyright 2022 Health Information Designs, LLC 2
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Forteo (Teriparatide) Clinical Criteria Logic 1. Is the client less than ( ) 18 years of age or have an open epiphyses? [manual] [ ] Yes – Deny [ ] No – Go to #2 2. Does the client have a diagnosis of Paget’s disease or primary hyperparathyroidism in the last 365 days? [ ] Yes – Deny [ ] No – Go to #3 3. Does the client have a diagnosis of osteoporosis in the last 730 days? [ ] Yes – Go to #4 [ ] No – Deny 4. Has the client had 1 claim for teriparatide in the last 90 days? [ ] Yes – Go to #5 [ ] No – Go to #6 5. Has the client had greater than or equal to ( ) 730 days of therapy in the last 5 years? [ ] Yes – Deny [ ] No – Approve (365 days) 6. Has the client had 1 claim for another medication for osteoporosis in the last 180 days? [ ] Yes – Approve (365 days) [ ] No - Deny October 18, 2022 Copyright 2022 Health Information Designs, LLC 3
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Forteo (Teriparatide) Clinical Criteria Logic Diagram Step 1 Is the client 18 years old or have an open epiphyses? [manual] Yes Deny Request No Step 2 Does the client have a diagnosis of Paget’s disease or primary hyperparathyroidism in the last 365 days? Yes Deny Request No Step 3 Does the client have a diagnosis of osteoporosis in the last 730 days? No Deny Request Yes Step 4 Has the client had 1 claim for teriparatide in the last 90 days? Step 5 Yes No Has the client had 730 days of therapy in the last 5 years? Yes Deny Request No Step 6 Has the client had 1 claim for another medication for osteoporosis in the last 180 days? Yes Approve Request (365 days) No Deny Request October 18, 2022 Copyright 2022 Health Information Designs, LLC 4
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Forteo (Teriparatide) Clinical Criteria Supporting Tables Step 2 (history of Paget’s disease or primary hyperparathyroidism) Required quantity: 1 Look back timeframe: 365 days ICD-10 code Description M880 OSTEITIS DEFORMANS OF SKULL M881 OSTEITIS DEFORMANS OF VERTEBRAE M88811 OSTEITIS DEFORMANS OF RIGHT SHOULDER M88812 OSTEITIS DEFORMANS OF LEFT SHOULDER M88819 OSTEITIS DEFORMANS OF UNSPECIFIED SHOULDER M88821 OSTEITIS DEFORMANS OF RIGHT UPPER ARM M88822 OSTEITIS DEFORMANS OF LEFT UPPER ARM M88829 OSTEITIS DEFORMANS OF UNSPECIFIED UPPER ARM M88831 OSTEITIS DEFORMANS OF RIGHT FOREARM M88832 OSTEITIS DEFORMANS OF LEFT FOREARM M88839 OSTEITIS DEFORMANS OF UNSPECIFIED FOREARM M88841 OSTEITIS DEFORMANS OF RIGHT HAND M88842 OSTEITIS DEFORMANS OF LEFT HAND M88849 OSTEITIS DEFORMANS OF UNSPECIFIED HAND M88851 OSTEITIS DEFORMANS OF RIGHT THIGH M88852 OSTEITIS DEFORMANS OF LEFT THIGH M88859 OSTEITIS DEFORMANS OF UNSPECIFIED THIGH M88861 OSTEITIS DEFORMANS OF RIGHT LOWER LEG M88862 OSTEITIS DEFORMANS OF LEFT LOWER LEG M88869 OSTEITIS DEFORMANS OF UNSPECIFIED LOWER LEG M88871 OSTEITIS DEFORMANS OF RIGHT ANKLE AND FOOT M88872 OSTEITIS DEFORMANS OF LEFT ANKLE AND FOOT M88879 OSTEITIS DEFORMANS OF UNSPECIFIED ANKLE AND FOOT M8888 OSTEITIS DEFORMANS OF OTHER BONES M8889 OSTEITIS DEFORMANS OF MULTIPLE SITES M889 OSTEITIS DEFORMANS OF UNSPECIFIED BONES E210 PRIMARY HYPERPARATHYROIDISM October 18, 2022 Copyright 2022 Health Information Designs, LLC 5
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days ICD-10 CODE M8000XA M8000XD M8000XG M8000XK M8000XP M8000XS M80011A M80011D M80011G M80011K M80011P M80011S M80012A M80012D M80012G M80012K October 18, 2022 DESCRIPTION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION Copyright 2022 Health Information Designs, LLC 6
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80012P M80012S M80019A M80019D M80019G M80019K M80019P M80019S M80021A M80021D M80021G M80021K M80021P M80021S M80022A M80022D October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING Copyright 2022 Health Information Designs, LLC 7
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80022G M80022K M80022P M80022S M80029A M80029D M80029G M80029K M80029P M80029S M80031A M80031D M80031G M80031K M80031P M80031S October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HUMERUS, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FOREARM, SEQUELA Copyright 2022 Health Information Designs, LLC 8
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80032A M80032D M80032G M80032K M80032P M80032S M80039A M80039D M80039G M80039K M80039P M80039S M80041A M80041D M80041G M80041K October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FOREARM, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FOREARM, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION Copyright 2022 Health Information Designs, LLC 9
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80041P M80041S M80042A M80042D M80042G M80042K M80042P M80042S M80049A M80049D M80049G M80049K M80049P M80049S M80051A M80051D M80051G October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HAND, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HAND, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED HAND, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING Copyright 2022 Health Information Designs, LLC 10
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80051K M80051P M80051S M80052A M80052D M80052G M80052K M80052P M80052S M80059A M80059D M80059G M80059K M80059P M80059S M80061A M80061D October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT FEMUR, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT FEMUR, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED FEMUR, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, Copyright 2022 Health Information Designs, LLC 11
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80061G M80061K M80061P M80061S M80062A M80062D M80062G M80062K M80062P M80062S M80069A M80069D M80069G M80069K M80069P October 18, 2022 SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT LOWER LEG, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT LOWER LEG, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION Copyright 2022 Health Information Designs, LLC 12
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80069S M80071A M80071D M80071G M80071K M80071P M80071S M80072A M80072D M80072G M80072K M80072P M80072S M80079A M80079D October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED LOWER LEG, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT ANKLE AND FOOT, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT ANKLE AND FOOT, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING Copyright 2022 Health Information Designs, LLC 13
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80079G M80079K M80079P M80079S M8008XA M8008XD M8008XG M8008XK M8008XP M8008XS M800AXA M800AXD M800AXG M800AXK M800AXP M800AXS M8080XA October 18, 2022 AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED ANKLE AND FOOT, SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, VERTEBRA(E), SEQUELA AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, INITIAL ENCOUNTER FOR FRACTURE AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION AGE-RELATED OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, OTHER SITE, SEQUELA OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, INITIAL ENCOUNTER FOR FRACTURE Copyright 2022 Health Information Designs, LLC 14
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M8080XD M8080XG M8080XK M8080XP M8080XS M80811A M80811D M80811G M80811K M80811P M80811S M80812A M80812D M80812G M80812K M80812P M80812S October 18, 2022 OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SITE, SEQUELA OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, INITIAL ENCOUNTER FOR FRACTURE OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT SHOULDER, SEQUELA OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, INITIAL ENCOUNTER FOR FRACTURE OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT SHOULDER, SEQUELA Copyright 2022 Health Information Designs, LLC 15
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of osteoporosis Required quantity: 1 Look back timeframe: 730 days M80819A M80819D M80819G M80819K M80819P M80819S M80821A M80821D M80821G M80821K M80821P M80821S M80822A M80822D M80822G M80822K M80822P October 18, 2022 OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, INITIAL ENCOUNTER FOR FRACTURE OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, UNSPECIFIED SHOULDER, SEQUELA OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, INITIAL ENCOUNTER FOR FRACTURE OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, RIGHT HUMERUS, SEQUELA OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, INITIAL ENCOUNTER FOR FRACTURE OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH ROUTINE HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH DELAYED HEALING OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH NONUNION OTHER OSTEOPOROSIS WITH CURRENT PATHOLOGICAL FRACTURE, LEFT HUMERUS, SUBSEQUENT ENCOUNTER FOR FRACTURE WITH MALUNION Copyright 2022 Health Information Designs, LLC 16
Texas Prior Authorization Program Clinical Criteria Forteo (Teriparatide) Step 3 (diagnosis of oste
Forteo (Teriparatide) Clinical Criteria Information Included in this Document Forteo (Teriparatide) Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior authorization criteria logic: a description of how the prior
Forteo Pen teriparatide injection User Manual Before you use your new FORTEO PEN, please read the entire front and back of this User Manual completely. Follow the directions carefully when using the FORTEO PEN. Do not share your pen or needles as this may risk transmission of infectious agents. Your FORTEO PEN contains 28 days of medication.File Size: 1MBPage Count: 6
Teriparatide is given as an injection under the skin (subcutaneously). It is injected in the thigh or abdomen once a day. It comes in a pen-shaped device to make the daily injection easier. The teriparatide pen contains enough medicine for 28 doses. It is important to use a new needle for each injection.
) FORTEO (teriparatide injection) Enrollment Form Please complete and fax this form to 1-866-436-7830 If you have any questions, please call FORTEO Connect at 1-866-4-FORTEO (1-866-436-7836), Monday-Friday 8am-10pm ET By enrolling in the FORTEO Connect Savings and Support P
Read the user manual booklet, which is included with the medicine, for instructions on how to use the teriparatide pen. Injection needles are not included with the pen but you can use Becto
Forteo (teriparatide) Multi-dose prefilled delivery device (pen) containing 28 daily dose of 20 mcg Tymlos (abaloparatide) Multi-dose prefilled delivery device (pen) containing 30 daily dose of 80 mcg FDA-APPROVED INDICATIONS: Forteo is recombinant human parathyroid hormone analog (1-34), [rhPTH(1-34)] indicated for:
Plans Preparation Manual, Volume 1 January 1, 2017 Design Geometrics and Criteria 2-1 Chapter 2 Design Geometrics and Criteria . 2.0 General . The implementation of design criteria is outlined in the following text. 1. Design Criteria: The design criteria presented in this manual are intended as
History of Nursing Education Unit Summary of Standards and Criteria Analysis and Summary of Strengths and Areas Needing Improvement SECTION TWO: STANDARDS AND CRITERIA I. Mission and Governance.8 NLNAC Criteria 1 NLNAC Criteria 2 NLNAC Criteria 3 NLNAC Criteria 4 II.
CURRICULUM VITAE : ANN SUTHERLAND HARRIS EDUCATION B.A. Honors (First Class) University of London, Courtauld Institute 1961 European art and architecture, 1250-1700 PhD. University of London, Courtauld Institute 1965 Dissertation title: Andrea Sacchi, 1599-1661 EMPLOYMENT 1964-5 Assistant Lecturer, Art Dept., University of Leeds. 1965-6 Assistant Lecturer, Barnard and Columbia College. 1965-71 .
